Dietary Intervention for Age-Related Macular Degeneration

(GLOVE Trial)

This trial explores how a low glycemic Mediterranean diet affects individuals with early to intermediate age-related macular degeneration (AMD), a common eye condition that can lead to vision loss. Researchers aim to determine if this diet can help manage blood sugar and carotenoid levels, potentially influencing AMD progression. Participants will follow a specific diet plan and wear a glucose monitor for two weeks over the course of a year. This trial suits those diagnosed with early to intermediate AMD who feel their current diet is unhealthy and have access to a computer or smartphone for online meetings. As an unphased trial, it offers participants the chance to contribute to groundbreaking research on dietary impacts on AMD.

If you are taking medications for diabetes, obesity, or cholesterol, you will need to stop them to participate in this trial. The trial does not specify about other medications, so it's best to discuss with the trial team.

Research has shown that following a Mediterranean diet, rich in vegetables, fruits, beans, fish, and grains, can help protect against age-related macular degeneration (AMD). Those who adhere to this diet have a lower risk of their AMD worsening. For instance, one study found that maintaining a Mediterranean diet reduced the risk of advanced AMD by up to 41%.

Unlike standard treatments for age-related macular degeneration, which often involve injections or medications aiming to slow vision loss, this dietary intervention focuses on modifying lifestyle through a low glycemic Mediterranean diet. This approach is unique because it doesn't rely on pharmaceuticals but instead uses dietary changes to manage the condition. Researchers are excited about this trial because it explores how diet can influence blood sugar levels and potentially improve eye health, offering a non-invasive and holistic alternative to traditional treatments.

Research has shown that a Mediterranean diet can help protect against age-related macular degeneration (AMD). Studies indicate that following this diet may lower the risk of developing advanced AMD by 34% to 41%. This trial will evaluate a low glycemic Mediterranean diet behavioral modification, where participants receive recommendations to modify their diets to be low glycemic and adhere to a Mediterranean diet. Rich in antioxidants and anti-inflammatory properties, this diet is believed to offer protective effects. It emphasizes fruits, vegetables, whole grains, and healthy fats like olive oil. This way of eating has been linked to slowing the progression of AMD, helping to maintain healthier eyes over time.¹³⁴⁶⁷